VRCA

2.7405.03%
NL

Noah L. Rosenberg

Chief Medical Officer

Dr. Noah L. Rosenberg, M.D., serves as Chief Medical Officer at Verrica Pharmaceuticals Inc. since March 2025. He served as Chief Medical Officer at Travere Therapeutics, Inc. since July 30, 2018. He oversaw the clinical development of its product pipeline. Dr. Rosenberg has clinical and therapeutic development experience, including advancing several mid- and late-stage programs across therapeutic areas through to commercialization. Dr. Rosenberg joined Travere Therapeutics from Medimetriks Pharmaceuticals, where he served as Chief medical officer from May 2014 to June 2018 and where he was responsible for the clinical development and medical strategy for pipeline candidates and multiple product launches, including the most recent approval of XepiTM. He served as Senior Advisor to Chief Executive Officer at Esperion Therapeutics, Inc. since February 26, 2014 until August 15, 2014 and served as its Chief Medical Officer since February 2012 until May 2014. Dr. Rosenberg has held senior posts in the pharmaceutical industry, including leadership roles in medical affairs, clinical development and administration in the US and globally at Pfizer and sanofi-aventis. He has experience working on compounds in all phases of drug development including late-stage drugs such as Lipitor and Lantus. Prior to joining Esperion, Dr. Rosenberg served as the Executive Director and Head of cardiovascular and metabolism clinical development for the Forest Research Institute, where he led the advancement of multiple late-stage clinical trials from April 2009 to January 2012. At Forest Research Institute (FRI), he led the successful in-licensing of the GK1-399 program and until his departure. He also coordinated the successful integration of the Forest cardiovascular and metabolism clinical development teams and managed the group through a highly productive period, helping to strengthen a pipeline that ultimately included compounds such as bystolic and azimilide. Dr. Rosenberg was trained in internal medicine residency at The Mount Sinai Hospital/Mount Sinai School of Medicine in New York City, where he also served as a faculty Member in internal medicine and emergency medicine. He earned a MD from Drexel University College of Medicine and a BA in natural sciences from The Johns Hopkins University.

Positions